DRUG RELATED PLATELET INHIBITION: IS THERE A ROLE FOR REDUCTION OF CEREBRAL MICROEMBOLI IN TRANSCATHETER AORTIC VALVE IMPLANTATION PATIENTS?

Charalampos Kalantzis; M Vavuranakis; Vassilis Voudris; Elias Kosmas; Konstantinos Toutouzas; Ioannis Iakovou; George Latsios; Konstantinos Kalogeras; Evangelia Bei; Carmen Moldovan; Dimitris Tousoulis; Manolis Vavuranakis

doi:https://doi.org/10.1016/s0735-1097(19)31813-3

doi.org/10.1016/s0735-1097(19)31813-3

DRUG RELATED PLATELET INHIBITION: IS THERE A ROLE FOR REDUCTION OF CEREBRAL MICROEMBOLI IN TRANSCATHETER AORTIC VALVE IMPLANTATION PATIENTS?

Charalampos Kalantzis

4

,

M Vavuranakis

5

,

..., Manolis Vavuranakis

28

Journal of the American College of Cardiology24.00

Volume: 73, Issue: 9, Pages: 1206 - 1206

Published: Mar 1, 2019

Abstract

Whether non-thienopyridines may protect patients more efficiently from microembolic events during TAVI has not been investigated. We hypothesized that ticagrelor+ASA will reduce the number of microemboli towards the cerebral circulation during TAVI comparing to the combination of...